Finally, it must be taken into account that genetic testing for ApoE, which is mainly conducted in research settings and is not yet widely available, cannot predict whether individuals will develop Alzheimer's disease, but only whether they may be more likely than others to do so; its clinical utility is therefore limited. This evidence concerns the gene APOE and Alzheimer disease.